Computerized Intervention for Teen Substance Abuse
(CARS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new computerized treatment for teens dealing with alcohol and cannabis use. It tests whether a computer task called the modified Approach-Avoidance Task (mAAT) can change automatic reactions to these substances. Participants will divide into two groups: one will receive the actual treatment, and the other will engage in a similar but inactive task for comparison. Teens aged 13-17 who have used both alcohol and cannabis in the last three months and are seeking treatment can participate, provided they have a caregiver who agrees to be involved. Follow-up checks will occur at one and three months after the treatment. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could shape future treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this computerized intervention is safe for teen substance abuse treatment?
Research shows that the modified Approach-Avoidance Task (mAAT) helps change automatic reactions to substances like alcohol and cannabis. Studies have examined how this training affects emotions and social relationships. Although these studies focus on effectiveness, they report no major safety issues. The absence of negative effects suggests that the treatment is generally safe.
This trial is labeled as "Not Applicable" for its phase, indicating a focus on understanding and measuring results rather than testing safety. This usually means the treatment has proven safe in other settings or similar trials. Therefore, participants can feel reasonably confident about the safety of the mAAT treatment.12345Why are researchers excited about this trial?
Researchers are excited about the modified Approach-Avoidance Task (mAAT) for teen substance abuse because it offers a unique way to address automatic approach biases, which are subconscious tendencies that might contribute to substance use. Unlike traditional methods, such as counseling or medication, that address conscious decision-making or chemical imbalances, the mAAT targets these underlying biases directly. This technique uses computerized tasks to retrain the brain's automatic responses, potentially leading to more effective and lasting behavior change. By focusing on these deep-seated patterns, the mAAT aims to provide a new avenue for intervention that could complement existing treatments.
What evidence suggests that this trial's treatments could be effective for teen substance abuse?
Research has shown that the modified Approach-Avoidance Task (mAAT) might help reduce substance use in teens. In this trial, participants in Group A will receive the mAAT designed to modify automatic approach bias. Studies have found that this can change automatic habits leading to alcohol or cannabis use. One study showed that this version of the mAAT successfully altered these automatic behaviors, potentially helping teens avoid substances. These early results suggest that the mAAT could be a promising tool for teens who want to reduce drinking or cannabis use. Meanwhile, participants in Group B will receive a version of the mAAT that does not aim to modify automatic approach bias, serving as a control.16789
Are You a Good Fit for This Trial?
This trial is for young people aged 13-17 who are looking for help with alcohol or cannabis use and have used both in the past three months. They must be willing to seek treatment and have a caregiver who can consent to their participation. Pregnant or breastfeeding individuals cannot join.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a computerized intervention for reducing cannabis and alcohol use
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.
- modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator